Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms.

Jequier Gygax M, Klein BD, White HS, Kim M, Galanopoulou AS.

Epilepsy Res. 2014 Jan;108(1):98-108. doi: 10.1016/j.eplepsyres.2013.10.015.

2.

Positive allosteric modulators to peptide GPCRs: a promising class of drugs.

Bartfai T, Wang MW.

Acta Pharmacol Sin. 2013 Jul;34(7):880-5. doi: 10.1038/aps.2013.20. Review.

3.

Galanin receptors and ligands.

Webling KE, Runesson J, Bartfai T, Langel U.

Front Endocrinol (Lausanne). 2012 Dec 7;3:146. doi: 10.3389/fendo.2012.00146.

4.

Synthesis and biological evaluation of novel pyrimidine derivatives as sub-micromolar affinity ligands of GalR2.

Sagi VN, Liu T, Lu X, Bartfai T, Roberts E.

Bioorg Med Chem Lett. 2011 Dec 1;21(23):7210-5. doi: 10.1016/j.bmcl.2011.09.033.

5.

Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala.

Bajo M, Madamba SG, Lu X, Sharkey LM, Bartfai T, Siggins GR.

Addict Biol. 2012 Jul;17(4):694-705. doi: 10.1111/j.1369-1600.2011.00360.x.

6.

Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2.

Elliott-Hunt CR, Holmes FE, Hartley DM, Perez S, Mufson EJ, Wynick D.

J Alzheimers Dis. 2011;25(3):455-62. doi: 10.3233/JAD-2011-110011.

7.

Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma.

Banerjee R, Henson BS, Russo N, Tsodikov A, D'Silva NJ.

Cell Signal. 2011 Jul;23(7):1110-8. doi: 10.1016/j.cellsig.2011.02.002.

9.

Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed.

Hoyer D.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):14943-4. doi: 10.1073/pnas.1010365107. No abstract available.

Items per page

Supplemental Content

Support Center